Progressive Muscular Atrophy

Neurologic Clinics

Volumn 33, Issue 4, 2015, Pages 761-773

  Liewluck, Teerin ^a,b   Saperstein, David S ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Lower motor neuron syndrome; Lower motor neuron onset ALS; PMA; Progressive muscular atrophy

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN; N ACETYLASPARTIC ACID; TAR DNA BINDING PROTEIN;

C9ORF72 GENE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; ELECTROMYOGRAPHY; GENE; GENE MUTATION; HEREDITARY MOTOR NEUROPATHY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMUNE MEDIATED NEUROPATHY; INCIDENCE; INCLUSION BODY MYOSITIS; KENNEDY DISEASE; LOWER MOTOR NEURON; MADRAS DISEASE; MONOMELIC AMYOTROPHY; MOTONEURON; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; MUSCLE ATROPHY; MYASTHENIA GRAVIS; MYOPATHY; NERVE DEGENERATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; PYRAMIDAL TRACT; REVIEW; SPINAL MUSCULAR ATROPHY; TRANSCRANIAL MAGNETIC STIMULATION; UPPER MOTOR NEURON; CLASSIFICATION; DISEASE MANAGEMENT; MUSCULAR ATROPHY, SPINAL; NEUROIMAGING; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MOTOR NEURON DISEASE; MUSCULAR ATROPHY, SPINAL; NEUROIMAGING; SEVERITY OF ILLNESS INDEX;

EID: 84945900072     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2015.07.005     Document Type: Review

References (85)

1. Visser J., de Jong J.M., de Visser M. The history of progressive muscular atrophy: syndrome or disease?. Neurology 2008, 70:723-727.
2. Ince P.G., Evans J., Knopp M., et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003, 60:1252-1258.
3. Sach M., Winkler G., Glauche V., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004, 127:340-350.
4. Kaufmann P., Pullman S.L., Shungu D.C., et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004, 62:1753-1757.
5. Mitsumoto H., Ulug A.M., Pullman S.L., et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007, 68:1402-1410.
6. Floyd A.G., Yu Q.P., Piboolnurak P., et al. Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology 2009, 72:498-504.
7. van der Graaff M.M., Sage C.A., Caan M.W., et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain 2011, 134:1211-1228.
8. Fisher K.M., Zaaimi B., Williams T.L., et al. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain 2012, 135:2849-2864.
9. Cervenakova L., Protas I.I., Hirano A., et al. Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS). J Neurol Sci 2000, 177:124-130.
10. Cudkowicz M.E., McKenna-Yasek D., Chen C., et al. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 1998, 43:703-710.
11. Restagno G., Lombardo F., Sbaiz L., et al. The rare G93D mutation causes a slowly progressing lower motor neuron disease. Amyotroph Lateral Scler 2008, 9:35-39.
12. Suzuki M., Irie T., Watanabe T., et al. Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: a clinical and neuropathological study. J Neurol Sci 2008, 268:140-144.
13. Norris F. Adult progressive muscular atrophy and hereditary spinal muscular atrophies. Handbook Clin Neurol 1991, 59:13-34.
14. Visser J., van den Berg-Vos R.M., Franssen H., et al. Disease course and prognostic factors of progressive muscular atrophy. Arch Neurol 2007, 64:522-528.
15. Kim W.K., Liu X., Sandner J., et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009, 73:1686-1692.
16. Rowland L.P. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve 2010, 41:161-165.
17. Mackay R. Course and prognosis in amyotrophic lateral sclerosis. Arch Neurol 1963, 8:17-27.
18. de Carvalho M., Scotto M., Swash M. Clinical patterns in progressive muscular atrophy (PMA): a prospective study. Amyotroph Lateral Scler 2007, 8:296-299.
19. Statland J.M., Barohn R.J., McVey A.L., et al. Patterns of weakness, classification of motor neuron disease & clinical diagnosis of sporadic ALS. Neurol Clin 2015, in press.
20. Van den Berg-Vos R.M., Visser J., Kalmijn S., et al. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. Arch Neurol 2009, 66:751-757.
21. Ringholz G.M., Appel S.H., Bradshaw M., et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005, 65:586-590.
22. Caselli R.J., Smith B.E., Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology 1995, 45:2005-2009.
23. Wicks P., Abrahams S., Leigh P.N., et al. Absence of cognitive, behavioral, or emotional dysfunction in progressive muscular atrophy. Neurology 2006, 67:1718-1719.
24. Raaphorst J., de Visser M., van Tol M.J., et al. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy. J Neurol Neurosurg Psychiatry 2011, 82:170-175.
25. Raaphorst J., van Tol M.J., Groot P.F., et al. Prefrontal involvement related to cognitive impairment in progressive muscular atrophy. Neurology 2014, 83:818-825.
26. Brachial amyotrophic diplpegia, leg amyotrophic diplegia, and isolated bulbar ALS, inpress.
27. Riku Y., Atsuta N., Yoshida M., et al. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis. BMJ Open 2014, 4:e005213.
28. Geser F., Stein B., Partain M., et al. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol 2011, 121:509-517.
29. Brownell B., Oppenheimer D.R., Hughes J.T. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970, 33:338-357.
30. Tsuchiya K., Sano M., Shiotsu H., et al. Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy exists: additional autopsy case with a clinical course of 19 years. Neuropathology 2004, 24:228-235.
31. Iwanaga K., Hayashi S., Oyake M., et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997, 146:139-143.
32. Tsuchiya K., Shintani S., Kikuchi M., et al. Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy: a clinicopathological study. J Neurol Sci 1999, 162:174-178.
33. van Rheenen W., van Blitterswijk M., Huisman M.H., et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 2012, 79:878-882.
34. van Blitterswijk M., Vlam L., van Es M.A., et al. Genetic overlap between apparently sporadic motor neuron diseases. PLoS One 2012, 7:e48983.
35. Cox L.E., Ferraiuolo L., Goodall E.F., et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 2010, 5:e9872.
36. Koppers M., van Blitterswijk M.M., Vlam L., et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2012, 33:837.e7-837.e13.
37. Vlam L., Schelhaas H.J., van Blitterswijk M., et al. Mutations in the TRPV4 gene are not associated with sporadic progressive muscular atrophy. Arch Neurol 2012, 69:790-791.
38. Kolb S.J., Kissel J.T. Spinal muscular atrophy. Neurol Clin 2015, in press.
39. Kennedy disease, inpress.
40. Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol Clin 2015, in press.
41. Wijesekera L.C., Mathers S., Talman P., et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009, 72:1087-1094.
42. Dimachkie M.M., Muzyka I.M., Katz J.S., et al. Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centers. J Clin Neuromuscul Dis 2013, 15:7-12.
43. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124(Suppl):96-107.
44. Brooks B.R., Miller R.G., Swash M., World Federation of Neurology Research Group on Motor Neuron Diseases, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
45. Cosottini M., Giannelli M., Siciliano G., et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005, 237:258-264.
46. Traynor B.J., Codd M.B., Corr B., et al. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 2000, 57:109-113.
47. Chahin N., Sorenson E.J. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve 2009, 40:126-129.
48. Parnes S., Karpati G., Carpenter S., et al. Hexosaminidase-A deficiency presenting as atypical juvenile-onset spinal muscular atrophy. Arch Neurol 1985, 42:1176-1180.
49. Flanagan E.P., Sandroni P., Pittock S.J., et al. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve 2012, 46:823-827.
50. Struck A.F., Salamat S., Waclawik A.J. Motor neuron disease with selective degeneration of anterior horn cells associated with non-Hodgkin lymphoma. J Clin Neuromuscul Dis 2014, 16:83-89.
51. van der Sluis R.W., Wolfe G.I., Nations S.P., et al. Post-radiation lower motor neuron syndrome. J Clin Neuromuscul Dis 2000, 2:10-17.
52. Boyer F.C., Tiffreau V., Rapin A., et al. Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy. Ann Phys Rehabil Med 2010, 53:34-41.
53. Debiasi R.L. West Nile virus neuroinvasive disease. Curr Infect Dis Rep 2011, 13:350-359.
54. Messacar K., Schreiner T.L., Maloney J.A., et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 2015, 385(9978):1662-1671.
55. Jawdat O., Statland J.M., Barohn R.J., et al. Regional variants: leg amyotrophic diplegia (LAD); brachial amyotropic diplegia (BAD); isolated bulbar ALS (IBALS). Neurol Clin 2015, in press.
56. Zhou B., Chen L., Fan D., et al. Clinical features of Hirayama disease in mainland China. Amyotroph Lateral Scler 2010, 11:133-139.
57. Jin X., Jiang J.Y., Lu F.Z., et al. Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy. BMC Musculoskelet Disord 2014, 15:349.
58. Pradhan S., Gupta R.K. Magnetic resonance imaging in juvenile asymmetric segmental spinal muscular atrophy. J Neurol Sci 1997, 146:133-138.
59. Hirayama K. Juvenile muscular atrophy of distal upper extremity (Hirayama disease). Intern Med 2000, 39:283-290.
60. Nalini A., Thennarasu K., Yamini B.K., et al. Madras motor neuron disease (MMND): clinical description and survival pattern of 116 patients from Southern India seen over 36 years (1971-2007). J Neurol Sci 2008, 269:65-73.
61. Worrall B.B., Rowland L.P., Chin S.S., et al. Amyotrophy in prion diseases. Arch Neurol 2000, 57:33-38.
62. Manabe Y., Shiro Y., Takahashi K., et al. A case of spinocerebellar ataxia accompanied by severe involvement of the motor neuron system. Neurol Res 2000, 22:567-570.
63. Tan C.F., Yamada M., Toyoshima Y., et al. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol 2009, 118:553-560.
64. Saperstein D.S. Chronic acquired demyelinating polyneuropathies. Semin Neurol 2008, 28:168-184.
65. Joint Task Force of the EFNS and the PNS European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 2010, 15:295-301.
66. Katz J.S., Wolfe G.I., Bryan W.W., et al. Electrophysiologic findings in multifocal motor neuropathy. Neurology 1997, 48:700-707.
67. Pakiam A.S., Parry G.J. Multifocal motor neuropathy without overt conduction block. Muscle Nerve 1998, 21:243-245.
68. Tan E., Lynn D.J., Amato A.A., et al. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol 1994, 51:194-200.
69. Katz J.S., Barohn R.J., Kojan S., et al. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 2002, 58:615-620.
70. Strigl-Pill N., Konig A., Schroder M., et al. Prediction of response to IVIg treatment in patients with lower motor neurone disorders. Eur J Neurol 2006, 13:135-140.
71. Burrell J.R., Yiannikas C., Rowe D., et al. Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes. PLoS One 2011, 6:e27041.
72. Simon N.G., Ayer G., Lomen-Hoerth C. Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?. Neurology 2013, 81:2116-2120.
73. Ellis C.M., Leary S., Payan J., et al. Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 1999, 67:15-19.
74. Bromberg M.B., Franssen H. Practical rules for electrodiagnosis in suspected multifocal motor neuropathy. J Clin Neuromuscul Dis 2015, 16:141-152.
75. Grimm A., Decard B.F., Athanasopoulou I., et al. Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy. J Neurol 2015, 262:870-880.
76. Hanemann C.O., Ludolph A.C. Hereditary motor neuropathies and motor neuron diseases: which is which. Amyotroph Lateral Scler Other Motor Neuron Disord 2002, 3:186-189.
77. Cappellari M., Cavallaro T., Ferrarini M., et al. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Syst 2011, 16:119-129.
78. Albertyn C.H., Sonderup M., Bryer A., et al. Acute intermittent porphyria presenting as progressive muscular atrophy in a young black man. S Afr Med J 2014, 104:283-285.
79. Nations S.P., Wolfe G.I., Amato A.A., et al. Distal myasthenia gravis. Neurology 1999, 52:632-634.
80. Rubin D.I., Litchy W.J. Severe, focal tibialis anterior and triceps brachii weakness in myasthenia gravis: a case report. J Clin Neuromuscul Dis 2011, 12:219-222.
81. Dabby R., Lange D.J., Trojaborg W., et al. Inclusion body myositis mimicking motor neuron disease. Arch Neurol 2001, 58:1253-1256.
82. Pestronk A. Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol 2011, 23:595-604.
83. Dimachkie M.M., Barohn R.J. Distal myopathies. Neurol Clin 2014, 32:817-842.
84. Alanazy M.H., White C., Korngut L. Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs. Amyotroph Lateral Scler Frontotemporal Degener 2014, 15:414-419.
85. Rudnicki S., McVey A.L., Jackson C.E., et al. Symptoms management and end of life care. Neurol Clin 2015, in press.